‘Concerning’ Rate of Benzo/Z-Drug Use in IBD
Patients with inflammatory bowel disease (IBD) are 70% more likely to use benzodiazepines and “Z-drugs” than are the general population, a large study from Canada suggests. Mood/anxiety disorders and sleep disorders are common in patients with IBD, but few studies have looked at use of benzodiazepine and Z-drugs (such as zolpidem, zaleplon, and eszopiclone) in … Read more